Angion is a clinical-stage biopharmaceutical company developing small molecule therapeutics to address fibrotic diseases and acute organ injuries. Its lead program is ANG-3070. Angion was founded in 1998 and headquartered in Uniondale, NY.
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $945.53 | A | |
| $16.99 | A | |
| $13.33 | A |